Literature DB >> 17355891

Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response.

Edward D Levin1, D Patrick Caldwell, Charles Perraut.   

Abstract

Pre-pulse inhibition (PPI) is a phenomenon of neurobehavioral plasticity in which the motor response to a startling sensory stimulus is inhibited by a preceding sensory stimulus of a lower intensity. The current experiment used tactile startle rather than acoustic startle to determine the generality of PPI across sensory modalities. PPI is easily modeled in experimental animals and serves as a useful method for determining the neural bases for sensorimotor plasticity, which can be disturbed in sensory modulation disorders. In the current study, female Sprague-Dawley rats were tested for tactile startle PPI after an auditory pre-pulse. The glutamate NMDA receptor antagonist dizocilpine (MK-801, 0.05 mg/kg) caused a nearly total blockade of the PPI effect (p<0.0005). The antipsychotic drug clozapine (1.25 mg/kg, p<0.001 and 2.5 mg/kg p<0.05) significantly attenuated the dizocilpine-induced PPI impairment. Interestingly, the lower clozapine dose did not by self enhance PPI and the higher clozapine dose when given alone caused a significant (p<0.05) PPI impairment relative to control. Nicotine (0.2 and 0.4 mg/kg) did not significantly interact with the other treatments, though the higher nicotine dose did show a trend toward attenuating the PPI impairment caused by the high clozapine dose. These effects were replicated in a second experiment of clozapine-dizocilpine interactions without nicotine treatment. This study shows that PPI of tactile startle is dramatically impaired by blocking NMDA activation and that the prototypic atypical antipsychotic drug clozapine can correct this deficit. This may be relevant to the action of clozapine in attenuating sensory gating deficits in schizophrenia and may point to new avenues of treatment for sensory modulation disorders in which there is excessive tactile response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355891      PMCID: PMC1976186          DOI: 10.1016/j.pbb.2007.02.005

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.

Authors:  M Ballmaier; M Zoli; R Mazzoncini; M Gennarelli; F Spano
Journal:  Psychopharmacology (Berl)       Date:  2001-09-11       Impact factor: 4.530

2.  Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex.

Authors:  R Depoortere; G Perrault; D J Sanger
Journal:  Behav Pharmacol       Date:  1999-02       Impact factor: 2.293

Review 3.  Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.

Authors:  M A Geyer; K Krebs-Thomson; D L Braff; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 4.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 5.  Atypical antipsychotics: mechanism of action.

Authors:  Philip Seeman
Journal:  Can J Psychiatry       Date:  2002-02       Impact factor: 4.356

6.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

7.  Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia.

Authors:  Bob Oranje; Clarine J Van Oel; Christine C Gispen-De Wied; Marinus N Verbaten; René S Kahn
Journal:  J Clin Psychopharmacol       Date:  2002-08       Impact factor: 3.153

8.  Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.

Authors:  Gary S Linn; Shobhit S Negi; Scott V Gerum; Daniel C Javitt
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 9.  Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research.

Authors:  Veena Kumari; Tonmoy Sharma
Journal:  Psychopharmacology (Berl)       Date:  2002-06-05       Impact factor: 4.530

10.  Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.

Authors:  Gwenaëlle Le Pen; Jean-Luc Moreau
Journal:  Neuropsychopharmacology       Date:  2002-07       Impact factor: 7.853

View more
  9 in total

1.  Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.

Authors:  Ignasi Oliveras; Ana Sánchez-González; Daniel Sampedro-Viana; Maria Antonietta Piludu; Cristóbal Río-Alamos; Osvaldo Giorgi; Maria G Corda; Susana Aznar; Javier González-Maeso; Cristina Gerbolés; Gloria Blázquez; Toni Cañete; Adolf Tobeña; Alberto Fernández-Teruel
Journal:  Psychopharmacology (Berl)       Date:  2017-02-02       Impact factor: 4.530

2.  Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.

Authors:  Patrick M Callahan; Alvin V Terry; Ashok Tehim
Journal:  Psychopharmacology (Berl)       Date:  2014-03-05       Impact factor: 4.530

3.  PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-09-02       Impact factor: 4.530

4.  The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-06-28       Impact factor: 4.530

5.  Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine.

Authors:  Cindy S Roegge; Charles Perraut; Xin Hao; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2007-02-22       Impact factor: 3.533

6.  Brainstem reflexes are hyperactive in patients with drug-induced akathisia.

Authors:  Baris Metin; Sinem Zeynep Metin; Aysegul Gunduz; Burc Cagri Poyraz; Mine Ozmen; Gunes Kiziltan; Meral E Kiziltan
Journal:  Neurol Sci       Date:  2017-07-05       Impact factor: 3.307

Review 7.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

8.  Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms.

Authors:  Sheraz Khoja; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  Front Cell Neurosci       Date:  2019-07-23       Impact factor: 5.505

9.  Perspectives on sensory processing disorder: a call for translational research.

Authors:  Lucy J Miller; Darci M Nielsen; Sarah A Schoen; Barbara A Brett-Green
Journal:  Front Integr Neurosci       Date:  2009-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.